Those 11 deals have a combined value of $64.4 billion, with the pharmaceuticals sector’s $30.45 billion in deals making up the largest portion of the total.
Here are the five top billion-dollar-plus healthcare deals that have been recorded in 2015.
1. AbbVie’s purchase of Pharmacyclics — $21 billion
2. Pfizer’s purchase of Hospira — $17 billion
3. Valeant Pharmaceuticals’ purchase of Salix Pharmaceuticals — $10.1 billion
4. Shire’s purchase of NPS Pharmaceuticals — $5.2 billion
5. Mallinckrodt’s purchase of Ikaria — $2.3 billion
More articles on healthcare finance:
House leaders in talks over $200B Medicare deal
12 recent hospital outlook and rating actions
10 healthcare CFOs in the headlines this week
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
